Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > 4.5 million shares traded after the close

<< Previous

Bullboard Posts

Next >>

Comment by Mannequinon Oct 28, 2023 12:02am

85 Views

Post# 35705386

RE:RE:RE:4.5 million shares traded after the close

We will soon see why the shares went to within 10 days

SPCEO1 wrote: No one owned that many shares prior to the offering and that amount of shares represents a little less than 10% of the total outstanding now and a little less than 20% of the shares outstanding before the deal. So, it seems tied to the deal in some way. Maybe it had to do with the private placement to Investisement Quebec.
l
Mannequin wrote:
Care to ponder?

Could it be a Wuebec fund moving it around after tanking the share price? Not being serious but not kidding either.

SPCEO1 wrote: That is a lot of shares and I wonder what that could be. Maybe just something related to the deal as no investor owned even half that many shares before the deal.